Search NASA⌕ Search

SEARCH · Search NASA

Results for “Preventative Compounds”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 181 records · Page 10

Antitumor activity of a novel and orally available inhibitor of serine palmitoyltransferase

Metabolic reprogramming is an essential hallmark of neoplasia. Therefore, targeting cancer metabolism, including lipid synthesis, has attracted much interest in recent years. Serine palmitoyltransferase (SPT) plays a key role in the initial and rate-limiting step of de novo sphingolipid biosynthesis, and inhibiting SPT activity prevents the proliferation of certain cancer cells. Here, we identified a novel and orally available SPT inhibitor, compound-2. Compound-2 showed an anti-proliferative effect in several cancer cell models, reducing the levels of the sphingolipids ceramide and sphingomyelin. In the presence of compound-2, exogenously added S1P partially compensated the intracellular sphingolipid levels through the salvage pathway by partially rescuing compound-2-induced cytotoxicity. This suggested that the mechanism underlying the anti-proliferative effect of compound-2 involved the reduction of sphingolipid levels. Indeed, compound-2 promoted multinuclear formation with reduced endogenous sphingomyelin levels specifically in a compound-2-sensitive cell line, indicating that the effect was induced by sphingolipid reduction. Furthermore, compound-2 showed potent antitumor activity without causing significant body weight loss in the PL-21 acute myeloid leukemia mouse xenograft model. Therefore, SPT may be an attractive therapeutic anti-cancer drug target for which compound-2 may be a promising new drug. - Highlights: • We discovered compound-2, a novel and orally available SPT inhibitor. • Compound-2 was cytotoxic against PL-21 acute myeloid leukemia cells. • Compound-2 showed antitumor activity in the PL-21 mouse xenograft model.

60 APPLIED LIFE SCIENCES↗

Risk assessment of coccidostatics during feed cross-contamination: Animal and human health aspects

Coccidiosis, an intestinal plasmodium infection, is a major infectious disease in poultry and rabbits. Eleven different coccidiostats are licensed in the EU for the prevention of coccidiosis in these animal species. According to their chemical nature and main biological activity, these compounds can be grouped as ionophoric (monensin, lasalocid sodium, salinomycin, narasin, maduramicin and semduramicin) or non-ionophoric (robenidine, decoquinate, nicarbazin, diclazuril, and halofuginone) substances. Coccidiostats are used as feed additives, mixed upon request into the compounded feed. During the technical process of commercial feed production, cross-contamination of feed batches can result in the exposure of non-target animals and induce adverse health effects in these animals due to a specific sensitivity of mammalian species as compared to poultry. Residue formation in edible tissues of non-target species may result in unexpected human exposure through the consumption of animal products. This review presents recent risk assessments performed by the Scientific Panel on Contaminants in the Food Chain (CONTAM) of the European Food Safety Authority (EFSA). The health risk to non-target species that would result from the consumption of cross-contaminated feed with coccidostats at levels of 2, 5 or 10% was found to be negligible for most animal species with the exception of salinomycin and monensin in horses because of the particular sensitivity for which toxicity may occur when cross-contamination exceeds 2% and 5% respectively. Kinetic data and tissue analyses showed that residues of coccidiostats may occur in the liver and eggs in some cases. However, the level of residues of each coccidiostat in edible animal tissues remained sufficiently low that the aggregate exposure of consumers would not exceed the established acceptable daily intake (ADI) of each coccidiostat. It could be concluded that technical cross-contamination of animal feeds would not be expected to adversely affect the health of consumers.

60 APPLIED LIFE SCIENCES↗

Modeling of internal mechanical failure of all-solid-state batteries during electrochemical cycling, and implications for battery design

This study is the first quantitative analysis of mechanical reliability of all-solid state batteries. Mechanical degradation of the solid electrolyte (SE) is caused by intercalation-induced expansion of the electrode particles, within the constrains of a dense microstructure. A coupled electro-chemo-mechanical model was implemented to quantify the material properties that cause an SE to fracture. The treatment of microstructural details is essential to the understanding of stress-localization phenomena and fracture. A cohesive zone model is employed to simulate the evolution of damage. In the numerical tests, fracture is prevented when electrode-particle's expansion is lower than 7.5% (typical for most Li-intercalating compounds) and the solid-electrolyte's fracture energy higher than G c = 4 J m -2 . Perhaps counter-intuitively, the analyses show that compliant solid electrolytes (with Young's modulus in the order of E SE = 15 GPa) are more prone to micro-cracking. This result, captured by our non-linear kinematics model, contradicts the speculation that sulfide SEs are more suitable for the design of bulk-type batteries than oxide SEs. Mechanical degradation is linked to the battery power-density. Fracture in solid Li-ion conductors represents a barrier for Li transport, and accelerates the decay of rate performance.

25 ENERGY STORAGE↗

Atomic hydrogen storage method and apparatus

Atomic hydrogen, for use as a fuel or as an explosive, is stored in the presence of a strong magnetic field in exfoliated layered compounds such as molybdenum disulfide or an elemental layer material such as graphite. The compound is maintained at liquid helium temperatures and the atomic hydrogen is collected on the surfaces of the layered compound which are exposed during delamination (exfoliation). The strong magnetic field and the low temperature combine to prevent the atoms of hydrogen from recombining to form molecules.

Woollam, J. A.↗

Atomic hydrogen storage

Atomic hydrogen, for use as a fuel or as an explosive, is stored in the presence of a strong magnetic field in exfoliated layered compounds such as molybdenum disulfide or an elemental layer material such as graphite. The compound is maintained at liquid temperatures and the atomic hydrogen is collected on the surfaces of the layered compound which are exposed during delamination (exfoliation). The strong magnetic field and the low temperature combine to prevent the atoms of hydrogen from recombining to form molecules.

Woollam, J. A.↗

Atomic hydrogen storage method and apparatus

Atomic hydrogen, for use as a fuel or as an explosive, is stored in the presence of a strong magnetic field in exfoliated layered compounds such as molybdenum disulfide or an elemental layer material such as graphite. The compounds maintained at liquid helium temperatures and the atomic hydrogen is collected on the surfaces of the layered compound which are exposed during delamination (exfoliation). The strong magnetic field and the low temperature combine to prevent the atoms of hydrogen from recombining to form molecules.

Woollam, J. A.↗

J-Channel Locks Potting to Compression Panel

Panel ends supported to prevent edge failure during testing. J-Channels attached to panel ends form mechanical lock with potting compound during elevated temperature tests. Not needed during room-temperature tests.

Royster, D. M.↗

Ultrahigh elastically compressible and strain-engineerable intermetallic compounds under uniaxial mechanical loading

Intermetallic compounds possess unique atomic arrangements that often lead to exceptional material properties, but their extreme brittleness usually causes fracture at a limited strain of less than 1% and prevents their practical use. Thus, it is critical for them to exhibit either plasticity or some form of structural transition to absorb and release a sufficient amount of mechanical energy before failure occurs. This study observes that the ThCr 2 Si 2 -structured intermetallic compound (CaFe 2 As 2 ) and a hybrid of its structure (CaKFe 4 As 4 ) with 2 μm in diameter and 6 μm in height can exhibit superelasticity with strain up to 17% through a reversible, deformation-induced lattice collapse, leading to a modulus of resilience orders of magnitude higher than that of most engineering materials. Such superelasticity also can enable strain engineering, which refers to the modification of material properties through elastic strain. Density functional theory calculations and cryogenic nanomechanical tests predict that superconductivity in CaKFe 4 As 4 could be turned on/off through the superelasticity process, before fracture occurs, even under uniaxial compression, which is the favorable switching loading mode in most engineering applications. Our results suggest that other members with the same crystal structure (more than 2500 intermetallic compounds) and substitution series based on them should be examined for the possibility of manifesting similar superelastic and strain-engineerable functional properties.

36 MATERIALS SCIENCE↗

Adverse health effects due to arsenic exposure: Modification by dietary supplementation of jaggery in mice

Populations of villages of eastern India and Bangladesh and many other parts of the world are exposed to arsenic mainly through drinking water. Due to non-availability of safe drinking water they are compelled to depend on arsenic-contaminated water. Generally, poverty level is high in those areas and situation is compounded by the lack of proper nutrition. The hypothesis that the deleterious health effects of arsenic can be prevented by modification of dietary factors with the availability of an affordable and indigenous functional food jaggery (sugarcane juice) has been tested in the present study. Jaggery contains polyphenols, vitamin C, carotene and other biologically active components. Arsenic as sodium-m-arsenite at low (0.05 ppm) and high (5 ppm) doses was orally administered to Swiss male albino mice, alone and in combination with jaggery feeding (250 mg/mice), consecutively for 180 days. The serum levels of total antioxidant, glutathione peroxidase and glutathione reductase were substantially reduced in arsenic-exposed groups, while supplementation of jaggery enhanced their levels in combined treatment groups. The serum levels of interleukin-1beta, interleukin-6 and TNF-alpha were significantly increased in arsenic-exposed groups, while in the arsenic-exposed and jaggery supplemented groups their levels were normal. The comet assay in bone marrow cells showed the genotoxic effects of arsenic, whereas combination with jaggery feeding lessened the DNA damage. Histopathologically, the lung of arsenic-exposed mice showed the necrosis and degenerative changes in bronchiolar epithelium with emphysema and thickening of alveolar septa which was effectively antagonized by jaggery feeding. These results demonstrate that jaggery, a natural functional food, effectively antagonizes many of the adverse effects of arsenic.

60 APPLIED LIFE SCIENCES↗

Glioblastoma Treatment: Bypassing the Toxicity of Platinum Compounds by Using Liposomal Formulation and Increasing Treatment Efficiency With Concomitant Radiotherapy

Purpose: Treatments of glioblastoma with cisplatin or oxaliplatin only marginally improve the overall survival of patients and cause important side effects. To prevent adverse effects, improve delivery, and optimize the tumor response to treatment in combination with radiotherapy, a potential approach consists of incorporating the platinum agent in a liposome. Methods and Materials: In this study, cisplatin, oxaliplatin, carboplatin, Lipoplatin (the liposomal formulation of cisplatin), and Lipoxal (the liposomal formulation of oxaliplatin) were tested on F98 glioma orthotopically implanted in Fischer rats. The platinum compounds were administered by intracarotid infusion and were assessed for the ability to reduce toxicity, improve cancer cell uptake, and increase survival of animals when combined or not combined with radiotherapy. Results: The tumor uptake was 2.4-fold more important for Lipoxal than the liposome-free oxaliplatin. Lipoxal also improved the specificity of oxaliplatin as shown by a higher ratio of tumor to right hemisphere uptake. Surprisingly, Lipoplatin led to lower tumor uptake compared with cisplatin. However, Lipoplatin had the advantage of largely reducing the toxicity of cisplatin and allowed us to capitalize on the anticancer activity of this agent. Conclusion: Among the five platinum compounds tested, carboplatin showed the best increase in survival when combined with radiation for treatment of glioma implanted in Fischer rats.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Pyruvic acid prevents Cu2+/Zn2+-induced neurotoxicity by suppressing mitochondrial injury

Highlights: • Pyruvic acid clearly suppressed Cu{sup 2+}/Zn{sup 2+}-induced neurotoxicity in mouse hypothalamic neuronal cells (GT1-7 cells). • Pyruvic acid significantly suppressed cytochrome c release into cytoplasm, an index of mitochondrial injury. • Pyruvic acid may be therapeutically beneficial for neurological diseases involving neuronal cell death. Zinc (Zn) is known as a co-factor for over 300 metalloproteins or enzymes, and has essential roles in many physiological functions. However, excessively high Zn concentrations are induced in pathological conditions such as interruption of blood flow in stroke or transient global ischemia-induced neuronal cell death. Furthermore, we recently found that copper (Cu{sup 2+}) significantly exacerbates Zn{sup 2+} neurotoxicity in mouse hypothalamic neuronal cells, suggesting that Zn{sup 2+} interaction with Cu{sup 2+} is important for the development of neurological disease. Meanwhile, organic acids such as pyruvic acid and citric acid are reported to prevent neuronal cell death induced by various stresses. Thus, in this study, we focused on organic acids and searched for compounds that inhibit Cu{sup 2+}/Zn{sup 2+}-induced neurotoxicity. Initially, we examined the protective effect of various organic acids on Cu{sup 2+}/Zn{sup 2+}-induced neurotoxicity, and found that pyruvic acid clearly suppresses Cu{sup 2+}/Zn{sup 2+}-induced neurotoxicity in GT1-7 cells. Next, we examined the protective mechanisms of pyruvic acid against Cu{sup 2+}/Zn{sup 2+}-induced neurotoxicity. Specifically, we examined the possibilities that pyruvic acid chelates Cu{sup 2+} and Zn{sup 2+} or suppresses the ER stress response, but found that neither was suppressed by pyruvic acid treatment. In contrast, pyruvic acid significantly suppressed cytochrome c release into cytoplasm, an index of mitochondrial injury, in a dose-dependent manner. These results suggest that pyruvic acid prevents Cu{sup 2+}/Zn{sup 2+}-induced neuronal cell death by suppressing mitochondrial injury. Based on our results, we assume that pyruvic acid may be therapeutically beneficial for neurological diseases involving neuronal cell death such as vascular dementia.

60 APPLIED LIFE SCIENCES↗

Proline-Rich Polypeptide 1 and G X -NH 2 : Molecular and Genetic Mechanisms of Hematopoiesis Regulation

LifeTime™ is a clinical-stage pharmaceutical company focused on that focuses on "fast tracked" small molecules designed to treat and prevent the recurrence of life-threatening chronic infectious and malignant diseases. It is a company focused on the clinical development and commercialization of promising new compounds for human therapeutics. Its lead compound is Beta LT™, an anti-cancer immune stimulant, which is currently in Phase I/II trials in Canada and waiting for Phase I/II start-up in America. While current approaches generally cause remissions, the few cells (or viruses) not killed by current therapy generally multiply, ultimately killing the person. To prevent this, they specialize in developing novel, to date completely non-toxic, long-term therapeutic products.

59 BASIC BIOLOGICAL SCIENCES↗

Salinomycin sensitizes antimitotic drugs-treated cancer cells by increasing apoptosis via the prevention of G2 arrest

Highlights: Black-Right-Pointing-Pointer Sal sensitizes antimitotic drugs-treated cancer cells. Black-Right-Pointing-Pointer Sal sensitizes them by prevention of G2 arrest and reduced cyclin D1 levels. Black-Right-Pointing-Pointer Sal also sensitizes them by increasing DNA damage and reducing p21 level. Black-Right-Pointing-Pointer A low concentration of Sal effectively sensitized the cancer cells to antimitotic drugs. -- Abstract: Here, we investigated whether Sal could sensitize cancer cells to antimitotic drugs. We demonstrated that Sal sensitized paclitaxcel (PAC)-, docetaxcel (DOC)-, vinblastin (VIN)-, or colchicine (COL)-treated cancer cell lines, suggesting that Sal has the ability to sensitize the cells to any form of microtubule-targeting drugs. Sensitization to the antimitotic drugs could be achieved with very low concentrations of Sal, suggesting that there is a possibility to minimize Sal toxicity associated with human cancer patient treatments. Sensitization by Sal increased apoptosis, which was observed by C-PARP production. Sal sensitized the cancer cells to antimitotic drugs by preventing G2 arrest, suggesting that Sal contributes to the induction of mitotic catastrophe. Sal generally reduced cyclin D1 levels in PAC-, DOC-, and VIN-treated cells. In addition, Sal treatment increased pH2AX levels and reduced p21 levels in antimitotic drugs-treated cells. These observations suggest that the mechanisms underlying Sal sensitization to DNA-damaging compounds, radiation, and microtubule-targeting drugs are similar. Our data demonstrated that Sal sensitizes cancer cells to antimitotic drugs by increasing apoptosis through the prevention of G2 arrest via conserved Sal-sensitization mechanisms. These results may contribute to the development of Sal-based chemotherapy for cancer patients treated with antimitotic drugs.

60 APPLIED LIFE SCIENCES↗

Mechanistic review of drug-induced steatohepatitis

Drug-induced steatohepatitis is a rare form of liver injury known to be caused by only a handful of compounds. These compounds stimulate the development of steatohepatitis through their toxicity to hepatocyte mitochondria; inhibition of beta-oxidation, mitochondrial respiration, and/or oxidative phosphorylation. Other mechanisms discussed include the disruption of phospholipid metabolism in lysosomes, prevention of lipid egress from hepatocytes, targeting mitochondrial DNA and topoisomerase, decreasing intestinal barrier function, activation of the adenosine pathway, increasing fatty acid synthesis, and sequestration of coenzyme A. It has been found that the majority of compounds that induce steatohepatitis have cationic amphiphilic structures; a lipophilic ring structure with a side chain containing a cationic secondary or tertiary amine. Within the last decade, the ability of many chemotherapeutics to cause steatohepatitis has become more evident coining the term chemotherapy-associated steatohepatitis (CASH). The mechanisms behind drug-induced steatohepatitis are discussed with a focus on cationic amphiphilic drugs and chemotherapeutic agents. - Highlights: • Reviewed the mechanisms underlying drug-induced steatohepatitis for many compounds • Mitochondrial dysfunction is critical in the development of drug-induced steatohepatitis. • Majority of drugs that induce steatohepatitis are cationic amphiphilic drugs. • Chemotherapeutics that induce CASH are cationic amphiphilic drugs. • Majority of drugs that induce steatohepatitis are carnitine palmitoyltransferase-I inhibitors.

60 APPLIED LIFE SCIENCES↗

Characterization of U-Zr fuel with alloying additive Sb for immobilizing fission product lanthanides

Fission product lanthanides can migrate to the fuel periphery and enhance fuel-cladding chemical interaction (FCCI). Adding Sb into the fuel alloy to bind lanthanides and thus to prevent lanthanides from migration has been proposed. The U-Zr fuel alloys were fabricated with compositions of U-10Zr-4.1Sb, U-10Zr-4.1Sb-4Ce, U-10Zr-2.07Sb, and U-10Zr-2.07Sb-2Ce wt.% by arc melting, and analyzed under scanning electron microscope (SEM) for the microstructure and elemental compositions. In the Ce-free alloy, Sb was found in Sb-Zr precipitates; while in the Ce-contained alloy, Sb was found in the form of intermetallic compounds Ce 4 Sb 3 and Ce 2 Sb without any Sb-Zr precipitates. In conclusion, antimony has the preference to bind Ce over Zr, indicating Sb can effectively prevent Ce interaction with Fe to the extent. Cerium is bound to Sb and no ternary intermetallic Ce-Sb-Zr compound was found.

36 MATERIALS SCIENCE↗

Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer

A series of new resveratrol analogues were designed and synthesized and their inhibitory activities against aromatase were evaluated. The crystal structure of human aromatase (PDB 3eqm) was used to rationalize the mechanism of action of the aromatase inhibitor 32 (IC{sub 50} 0.59 {mu}M) through docking, molecular mechanics energy minimization, and computer graphics molecular modeling, and the information was utilized to design several very potent inhibitors, including compounds 82 (IC{sub 50} 70 nM) and 84 (IC{sub 50} 36 nM). The aromatase inhibitory activities of these compounds are much more potent than that for the lead compound resveratrol, which has an IC{sub 50} of 80 {mu}M. In addition to aromatase inhibitory activity, compounds 32 and 44 also displayed potent QR2 inhibitory activity (IC{sub 50} 1.7 {mu}M and 0.27 {mu}M, respectively) and the high-resolution X-ray structures of QR2 in complex with these two compounds provide insight into their mechanism of QR2 inhibition. The aromatase and quinone reductase inhibitors resulting from these studies have potential value in the treatment and prevention of cancer.

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗

Microstructural characterization of annealed U-12Zr-4Pd and U-12Zr-4Pd-5Ln: Investigating Pd as a metallic fuel additive

Here, palladium is being investigated as a potential additive to metallic fuel to control fuel-cladding chemical interaction (FCCI). A primary cause of FCCI is the lanthanide fission products moving to the fuel periphery and interacting with the cladding. This interaction will lead to wastage of the cladding and eventually to a cladding breach. The current study is a scanning electron microscopy (SEM) and transmission electron microscopy (TEM) characterization of annealed U-12Zr-4Pd and U-12Zr-4Pd-5Ln, where Ln=53Nd-25Ce-16Pr-6La. The present study shows that Pd preferentially binds the lanthanides, which will prevent lanthanide migration and interaction with the cladding. The SEM analysis indicates the 1:1 Pd-Ln compound is being formed, while the TEM analysis, due to higher resolution, found the 1:1 compound, as well as Pd-rich compounds Pd 2 Ln and Pd 3 Ln 2 .

11 NUCLEAR FUEL CYCLE AND FUEL MATERIALS↗

Characterization of U-10Zr-2Sn-2Sb and U-10Zr-2Sn-2Sb-4Ln to assess Sn+Sb as a mixed additive system to bind lanthanides

In this paper, tin and antimony are being investigated as potential additives to metallic fuel to control fuel-cladding chemical interaction (FCCI). A primary cause of FCCI is lanthanide fission products moving to the fuel periphery and interacting with the cladding. This interaction can lead to wastage of the cladding and, given enough time or burn-up, eventually to a cladding breach. The current study involves a microstructural characterization of as-cast and annealed U-10Zr-2Sn-2Sb and U-10Zr-2Sn-2Sb-4Ln, where Ln = 53Nd-25Ce-16Pr-6La, all in wt %, as alloys which could prevent FCCI. Scanning electron microscopy (SEM) analysis and X-ray powder diffraction indicates the additive-Zr compound in U-10Zr-2Sn-2Sb is Zr 5 (Sn,Sb) 3 , while the additive-Ln compound being formed in U-10Zr-2Sn-2Sb-4Ln is Ln 5 (Sn,Sb) 4 , with significantly more Sb than Sn (37 at. % versus 6 at. %, respectively). The bulk of the Sn, with a small amount of Sb, remained as Zr 5 (Sn,Sb) 3 precipitates. Finally, the potential benefits of a mixed additive system, along with relative stabilities of the intermetallic compounds, are discussed.

11 NUCLEAR FUEL CYCLE AND FUEL MATERIALS↗